Omada Health, Inc. (OMDA)
NASDAQ:OMDA
Want to see OMDA full AI Analyst Report?
OMDA Stock Chart & Stats
$14.14
-$4.40(-19.47%)
At close: 4:00 PM EDT
$14.14
-$4.40(-19.47%)
Day’s Range― - ―
52-Week Range$10.28 - $28.40
Previous Close$18.29
Volume2.54M
Average Volume (3M)1.08M
Market Cap
$981.49M
Enterprise Value$769.73M
Total Cash (Recent Filing)$211.76M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.23
Next Earnings
Aug 06, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding59,448,505
10 Day Avg. Volume1,245,375
30 Day Avg. Volume1,082,124
Financial Highlights & Ratios
PEG Ratio0.97
Price to Book (P/B)4.01
Price to Sales (P/S)3.54
P/FCF Ratio54.46
Enterprise Value/Market Cap0.78
Enterprise Value/Revenue2.72
Enterprise Value/Gross Profit4.10
Enterprise Value/Ebitda-575.28
Forecast
1Y Price Target
$23.30Price Target Upside64.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)0.07
Revenue Forecast (FY)$326.51M
Bulls Say, Bears Say
Bulls Say
Diversified Product MomentumMomentum across diabetes, hypertension, cholesterol, and other cardiometabolic programs reduces reliance on any single therapy and supports more stable membership growth and revenue diversification.
GLP-1 Program AdoptionGrowing adoption of GLP-1 therapies and the GLP-1 Flex Care program expands the addressable market and makes employers more likely to pay for clinical support, which should increase revenue per enrolled member.
Profitability And Margin ImprovementAchievement of positive EBITDA and targeted gross margins, supported by disciplined expense control and AI-driven efficiencies, indicates a clearer path to sustained profitability and cash generation.
Bears Say
Investment-driven Margin PressurePlanned increases in business investment and new program launches could compress margins before anticipated revenue gains and efficiency improvements materialize.
Modeling And Growth UncertaintyReliance on predictive enrollment models that may overstate new member counts introduces uncertainty into future growth and revenue projections.
Valuation And Investor Sentiment RiskBroad valuation compression in the healthcare IT sector and investor perception of the company primarily as a GLP-1 play could weigh on the stock despite improving operational fundamentals.
Omada Health, Inc. News
OMDA FAQ
What was Omada Health, Inc.’s price range in the past 12 months?
Omada Health, Inc. lowest stock price was $10.28 and its highest was $28.40 in the past 12 months.
What is Omada Health, Inc.’s market cap?
Omada Health, Inc.’s market cap is $981.49M.
When is Omada Health, Inc.’s upcoming earnings report date?
Omada Health, Inc.’s upcoming earnings report date is Aug 06, 2026 which is in 71 days.
How were Omada Health, Inc.’s earnings last quarter?
Omada Health, Inc. released its earnings results on May 07, 2026. The company reported -$0.05 earnings per share for the quarter, beating the consensus estimate of -$0.128 by $0.078.
Is Omada Health, Inc. overvalued?
According to Wall Street analysts Omada Health, Inc.’s price is currently Undervalued.
Does Omada Health, Inc. pay dividends?
Omada Health, Inc. does not currently pay dividends.
What is Omada Health, Inc.’s EPS estimate?
Omada Health, Inc.’s EPS estimate is -0.02.
How many shares outstanding does Omada Health, Inc. have?
Omada Health, Inc. has 59,448,505 shares outstanding.
What happened to Omada Health, Inc.’s price movement after its last earnings report?
Omada Health, Inc. reported an EPS of -$0.05 in its last earnings report, beating expectations of -$0.128. Following the earnings report the stock price went down -9.634%.
Which hedge fund is a major shareholder of Omada Health, Inc.?
Currently, no hedge funds are holding shares in OMDA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Omada Health, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$23.30 (64.78% Upside)
$23.30 (64.78% Upside)
Blogger Sentiment
Bullish
OMDA Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 5.5%
Last 30 Days ▼ 5.5%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-2.81%
Trailing 12-Months
Asset Growth
114.47%
Trailing 12-Months
Company Description
Omada Health, Inc.
Omada Health is a U.S.-based virtual-care provider offering clinically validated programs for chronic conditions like cardiometabolic disease, musculoskeletal care, and behavioral health—delivered digitally between doctor visits.
OMDA Company Deck
OMDA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong growth and improving financial health: double-digit revenue growth (42% YoY), a key membership milestone (1.025M members, +51% YoY), margin expansion (GAAP 62%, non-GAAP 64%), positive adjusted EBITDA in Q1 and an upward revision to full-year guidance. Commercial momentum was highlighted by relationships with all three large PBMs and inclusion in Optum Rx and Lilly programs, alongside differentiated clinical evidence for the GLP-1 Care Track. Near-term headwinds are mostly transitional or tactical — cohort composition pressuring blended revenue per member, early-stage nature of some prescribing channels with material revenue expected more in 2027, modest device/shipping cost pressure (~$1M) and competitive multi-vendor PBM environments. Overall, the positives materially outweigh the manageable near-term challenges.View all OMDA earnings summariesOMDA Stock 12 Month Forecast
Average Price Target
$23.30
▲(64.78% Upside)
Technical Analysis
Teladoc
―
American Well
―
GoodRx Holdings
―
Privia Health Group
―
Hinge Health, Inc. Class A
―
Ownership Overview
5.09% Insiders
12.14% Mutual Funds
44.98% Other Institutional Investors
32.20% Public Companies and
Individual Investors